Market Place
Sourcing Support
Halozyme Provides Update on Non-Binding Proposal with Evotec
18 Nov 2024 //
PR NEWSWIRE
Halozyme makes 2 billion euro buyout offer for drug developer Evotec
15 Nov 2024 //
REUTERS
Comment on Media Report
14 Nov 2024 //
ACCESSWIRE
Evotec attracts private equity buyout interest
11 Nov 2024 //
FIERCE BIOTECH
Evotec Soars on Triton’s 10% Stake, Weighs Buyout Bid
11 Nov 2024 //
REUTERS
Evotec SE Reports 9M 2024 Results Amid Market Challenges
06 Nov 2024 //
ACCESSWIRE
Evotec Sells API Manufacturing Facility to Monacum Partners
05 Nov 2024 //
ACCESSWIRE
Evotec to Announce 9-Month 2024 Results on Nov 6, 2024
30 Oct 2024 //
ACCESSWIRE
Evotec and Novo Nordisk in technology development partnership
26 Sep 2024 //
REUTERS
Scientist.com and Evotec Partner to Accelerate Drug Discovery and Development
09 Sep 2024 //
BUSINESSWIRE
Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery
05 Sep 2024 //
BUSINESSWIRE
Evotec Chief Business Officer Steps Down
03 Sep 2024 //
CONTRACT PHARMA
Evotec Initiates “Priority Reset” Cutting 400 Roles
19 Aug 2024 //
CONTRACT PHARMA
Evotec eyes 400 layoffs, citing `challenging market`
14 Aug 2024 //
FIERCE BIOTECH
Evotec Progresses In Neuroscience Partnership With Bristol Myers Squibb
08 Aug 2024 //
ACCESSWIRE
Evotec SE Reports First Half-year 2024 Results on 14 August 2024
07 Aug 2024 //
ACCESSWIRE
65LAB and Duke-NUS award US$1.85 million to combat chronic inflammation
26 Jul 2024 //
PRESS RELEASE
Evotec & Pfizer Partner On Early Discovery For Metabolic And Infectious Diseases
11 Jul 2024 //
PHARMABIZ
Evotec, Pfizer Enter Multi-Year Master Research Collaboration
10 Jul 2024 //
CONTRACT PHARMA
Evotec and Pfizer Collaborate to Advance Drug Discovery in France
10 Jul 2024 //
ACCESSWIRE
Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz
08 Jul 2024 //
PRESS RELEASE
Tubulis` TUB-040 Gets FDA Fast Track For Ovarian Cancer
27 Jun 2024 //
PRESS RELEASE
DOD enlists Evotec subsidiary in antibody manufacturing program
26 Jun 2024 //
FIERCE PHARMA
Just – Evotec Selected For DoD Manufacturing Optimization Program
25 Jun 2024 //
PRESS RELEASE
beLAB1407 to develop novel approach for cardiovascular diseases
24 Jun 2024 //
PRESS RELEASE
Tubulis Doses First Patient In TUB-040 Phase I/IIa Cancer Trial
20 Jun 2024 //
PRESS RELEASE
Evotec Reaches Milestone in Neuroscience Collaboration with Bristol Myers Squibb
13 Jun 2024 //
PHARMABIZ
Evotec SE: Results of the Annual General Meeting 2024
10 Jun 2024 //
PRESS RELEASE
Evotec And QIAGEN Partner On Multi-Omics Data Insights Software
03 Jun 2024 //
PRESS RELEASE
Aurobac Presents R&D Strategy And New Boehringer Ingelheim Program
03 Jun 2024 //
PRESS RELEASE
Evotec Collaborates On Obesity And Metabolic Disease Research
30 May 2024 //
PRESS RELEASE
Evotec Extends Huntington`s Disease Collaboration With CHDI
28 May 2024 //
PRESS RELEASE
Evotec Chdi Huntington`s Collaboration: Strategic Drug Discovery Extended
28 May 2024 //
ACCESSWIRE
Evotec receives NASDAQ notice related to late filing of 20-F
27 May 2024 //
PRESS RELEASE
Evotec Partner Kazia Completes EVT801 Phase 1 Cancer Trial
22 May 2024 //
PRESS RELEASE
Evotec Reports Q1 2024 Results and Provides Corporate Update
22 May 2024 //
ACCESSWIRE
Evotec shuts down gene therapy business in light of Q1 2024 loss
22 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Centogene and Evotec discover promising new molecule to treat Gaucher disease
16 May 2024 //
PHARMABIZ
Evotec SE to Announce Results for First Quarter 2024 on 22 May 2024
15 May 2024 //
ACCESSWIRE
Centogene and Evotec Discover New Potential Treatment for Gaucher Disease
14 May 2024 //
CONTRACT PHARMA
Bayer, Evotec Partner to Advance Precision Cardiology Therapies
30 Apr 2024 //
PRESS RELEASE
Evotec Presents 2023 Results, Focuses On Profitable Growth
24 Apr 2024 //
PRESS RELEASE
Evotec Presents 2023 Results, Resets Profitable Growth Focus
24 Apr 2024 //
ACCESSWIRE
Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer
23 Apr 2024 //
ACCESSWIRE
EVOTEC, Variant Bio Partner On Fibrosis Treatments
18 Apr 2024 //
PR NEWSWIRE
Evotec and Variant Bio Partner to Discover & Develop Treatments for Fibrosis
18 Apr 2024 //
PRESS RELEASE
Evotec welcomes Aurélie Dalbiez as Chief People Officer
17 Apr 2024 //
ACCESSWIRE
Evotec SE to Announce Results for Fiscal Year 2023 on 24 April 2024
17 Apr 2024 //
ACCESSWIRE
Tubulis Raises €128M In Series B2 For ADC Pipeline Development
14 Mar 2024 //
PRESS RELEASE
Evotec And Claris Ventures Partner To Accelerate Clinical Programs
06 Mar 2024 //
PRESS RELEASE
Developing novel strategies against tuberculosis and malaria
21 Feb 2024 //
PRESS RELEASE
Just – Evotec Expands HIV Antibody Manufacturing Deal With ABL
07 Feb 2024 //
PRESS RELEASE
Evotec SE: Invitation to Conference Call
22 Jan 2024 //
ACCESSWIRE
Evotec says it promptly reported share trades withheld by former CEO
22 Jan 2024 //
REUTERS
Evotec And Crohn`s & Colitis Foundation Partner On IBD Therapies
10 Jan 2024 //
PRESS RELEASE
Evotec Reports Progress In BMS Neuroscience Partnership
08 Jan 2024 //
PRESS RELEASE
Evotec CEO Werner Lanthaler resigns
05 Jan 2024 //
ENDPTS
Evotec And Owkin Partner On AI-Driven Oncology And I&I Therapeutics
04 Jan 2024 //
PRESS RELEASE
Evotec announces CEO transition
03 Jan 2024 //
PRESS RELEASE
Dewpoint Therapeutics Enters Strategic Partnership with Evotec
07 Nov 2023 //
GLOBENEWSWIRE
